These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3408)

  • 41. [Acetylation polymorphism in lung cancer].
    Laredo Quesada JM; Jara Sánchez C; Benítez Rodríguez J; Fernández Gundín MJ; Vargas Castrillón E; Muñoz González JJ; Llerena Ruiz A; Cobaleda Polo J; Pérez-Manga G
    An Med Interna; 1991 Feb; 8(2):66-8. PubMed ID: 1893005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzymatic conjugation of foreign chemical compounds by rabbit lung and liver.
    Gram TE; Litterst CL; Mimnaugh EG
    Drug Metab Dispos; 1974; 2(3):254-8. PubMed ID: 4152872
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes in acetylator phenotype over the lifespan in the Wistar rat.
    Lares-Asseff I; Camacho GA; Guillé AJ; Toledo AR; Trujillo F; Reyes RE; Juárez HM; Pérez G
    Mech Ageing Dev; 2006 Jan; 127(1):73-8. PubMed ID: 16298418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetylator phenotype in patients with allergic diseases and its clinical significance.
    Orzechowska-Juzwenko K; Milejski P; Patkowski J; Nittner-Marszalska M; Malolepszy J
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):420-5. PubMed ID: 2258251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.
    Sarma GR; Kailasam S; Datta M; Loganathan GK; Rahman F; Narayana AS
    Indian Pediatr; 1990 Feb; 27(2):134-42. PubMed ID: 2361757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.
    Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T
    Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
    Hein DW; Rustan TD; Bucher KD; Furman EJ; Martin WJ
    J Pharmacol Exp Ther; 1991 Jul; 258(1):232-6. PubMed ID: 2072298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro.
    Hein DW; Hirata M; Weber WW
    Pharmacology; 1981; 23(4):203-10. PubMed ID: 6976581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphic acetylation of drugs in rabbits.
    Gordon GR; Shafizadeh AG; Peters JH
    Xenobiotica; 1973 Mar; 3(3):133-50. PubMed ID: 4729680
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.
    McQueen CA; Maslansky CJ; Glowinski IB; Crescenzi SB; Weber WW; Williams GM
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1269-72. PubMed ID: 6951172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetylation of drugs. Observations on the properties of partially purified N-acetyltransferase from peripheral blood of rabbit.
    Drummond GS; Kelker HC; Weber WW
    Biochem J; 1980 Apr; 187(1):157-62. PubMed ID: 7406858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic kinetics of p-aminobenzoic acid in rabbits.
    Song DJ; Ho Y; Hsu KY
    Biopharm Drug Dispos; 1999 Jul; 20(5):263-70. PubMed ID: 10594871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of pyruvic acid on the pharmacokinetics of sulphadiazine in rabbits.
    Hsu KY; Song DJ; Ho Y
    Biopharm Drug Dispos; 1995 Apr; 16(3):233-44. PubMed ID: 7787135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacokinetics of isoniazid.
    Weber WW; Hein DW
    Clin Pharmacokinet; 1979; 4(6):401-22. PubMed ID: 391461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetylator phenotype determination in the rabbit: sulphamethazine or sulphadiazine, the choice of a substrate.
    du Souich P; Courteau H
    J Pharm Pharmacol; 1981 Apr; 33(4):261-3. PubMed ID: 6115918
    [No Abstract]   [Full Text] [Related]  

  • 57. Case Study 10: A Case to Investigate Acetyl Transferase Kinetics.
    Dumouchel JL; Kramlinger VM
    Methods Mol Biol; 2021; 2342():781-808. PubMed ID: 34272717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A semi-automated Bratton & Marshall micromethod for determining acetylator phenotype of rabbits using the Abbott Bichromatic Analyzer-100.
    Whitehouse LW; Paul CJ
    J Clin Chem Clin Biochem; 1979 Aug; 17(8):533-6. PubMed ID: 501298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylator phenotype in patients with breast cancer.
    Bulovskaya LN; Krupkin RG; Bochina TA; Shipkova AA; Pavlova MV
    Oncology; 1978; 35(4):185-8. PubMed ID: 704038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of ketoprofen on the pharmacokinetics of sulphadimethoxine in fast and slow acetylator rabbits.
    Imamura Y; Mori H; Otagiri M
    J Pharm Pharmacol; 1990 Jan; 42(1):62-3. PubMed ID: 1969955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.